Eastern Mediterranean (WHO region) vs El Salvador: Hypertension effective treatment coverage (controlled hypertension)
Eastern Mediterranean (WHO region)
15.5%
in 2019
El Salvador
39.4%
in 2019
Eastern Mediterranean (WHO region) rank
7th
El Salvador rank
9th
Hypertension effective treatment coverage (controlled hypertension) over time
- Eastern Mediterranean (WHO region)
- El Salvador
How they compare
El Salvador currently reports 39.4% against 15.5% in Eastern Mediterranean (WHO region), a difference of 23.9%.
That makes El Salvador's figure about 2.5 times Eastern Mediterranean (WHO region)'s.
Across all 30 years both countries report, El Salvador has been ahead every year.
Eastern Mediterranean (WHO region) ranks 7th and El Salvador ranks 9th of 11 groups.
El Salvador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eastern Mediterranean (WHO region) | El Salvador | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 4.9% | 14.0% | 9.1% | El Salvador |
| 2000s | 8.4% | 23.3% | 14.9% | El Salvador |
| 2010s | 13.9% | 35.5% | 21.6% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Eastern Mediterranean (WHO region) or El Salvador?
- El Salvador, at 39.4% against 15.5% in Eastern Mediterranean (WHO region) as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Eastern Mediterranean (WHO region) and El Salvador?
- 23.9%, with El Salvador ahead.
- How many years of comparable data are there for Eastern Mediterranean (WHO region) and El Salvador?
- 30 years are reported by both, from 1990 to 2019.
- How do Eastern Mediterranean (WHO region) and El Salvador rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Eastern Mediterranean (WHO region) ranks 7th and El Salvador ranks 9th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.